S. Kojima et al. / Tetrahedron 59 (2003) 255–265
263
4
All reactions were carried out under N2. THF was freshly
distilled from Na-benzophenone. Ethanol was distilled from
magnesium. All other solvents were distilled from CaH2.
Preparative thin layer chromatography was carried out on
(CDCl3) d 273.4 (q, JFF¼10.1 Hz, 6F), 274.6 (q,
4JFF¼10.1 Hz, 6F); 31P NMR (CDCl3) d 223.5. Anal.
calcd for C32H21F12O3P: C, 53.95; H, 2.97. Found: C, 54.04;
H, 2.91.
plates of Merck silica gel 60 GF254
.
4.1.3. (SpP,1S p,2S p)-1-(2-Hydroxy-1,2-diphenylethyl)-
3,3,30,30-tetrakis(trifluoromethyl)-1,10-spirobi[3H,2,1l 5-
benzoxaphosphole] (14-threo-A). To P–H (equatorial)
phosphorane 10 (201 mg, 0.389 mmol) in THF (2 mL) was
added n-BuLi (0.27 mL, 0.421 mol) at 08C. To this solution
was added cis-stilbene oxide (86.9 mg, 0.443 mmol) in THF
(2 mL) and the resulting mixture was stirred at rt for 5 h.
The solution was quenched with water, extracted with Et2O
and the combined organic solvents were washed with water
and brine. This was followed by drying over anhydrous
MgSO4 and concentration in vacuo. Separation of the
residue on TLC (hexane–Et2O¼9:1) followed by recrys-
tallization (hexane–CH2Cl2) gave 14-threo-A (72.1 mg,
26%). Mp 196–1978C (dec); 1H NMR (CDCl3) d 8.03 (br s,
2H), 7.75–7.54 (m, 6H), 7.02–6.59 (m, 10H), 5.27 (dd,
4.1.1. (SpP,1S p,2R p)-1-(2-Ethoxycarbonyl-2-hydroxy-1-
phenylethyl)-3,3,30,30-tetrakis(trifluoromethyl)-1,10-
spirobi[3H,2,1l 5-benzoxaphosphole] (11-erythro-A)
and (SpP,1R p,2S p)-1-(2-ethoxycarbonyl-2-hydroxy-1-
phenylethyl)-3,3,30,30-tetrakis(trifluoromethyl)-1,10-
spirobi[3H,2,1l 5-benzoxaphosphole] (11-erythro-B). To
P–H (equatorial) phosphorane 10 (214 mg, 0.415 mmol) in
THF (5 mL) was added n-BuLi (0.27 mL, 0.427 mol) at
08C. To this solution was added ethyl trans-3-phenyloxir-
anecarboxylate (72.0 mg, 0.374 mmol) in THF (2 mL) and
the resulting mixture was stirred at rt for 11 h. The solution
was quenched with 1 M HCl, extracted with Et2O and the
combined organic solvents were washed with water and
brine. This was followed by drying over anhydrous MgSO4
and concentration in vacuo. Separation of the residue on
TLC (hexane–Et2O¼3:1) followed by recrystallization
(hexane–CH2Cl2) gave 11-erythro-A (10.8 mg, 4%) and
11-erythro-B (23.5 mg, 8%). 11-erythro-A: mp 211.5–
2
J¼10.3 Hz, JPH¼8.3 Hz, 1H), 4.02 (dd, J¼10.3 Hz,
2JPH¼17.1 Hz, 1H), 3.72 (s, 1H); 19F NMR (CDCl3) d
273.7 (br s, 6F), 274.5 (br s, 6F); 31P NMR (CDCl3) d
219.3. Anal. calcd for C32H21F12O3P: C, 53.95; H, 2.97.
Found: C, 54.00; H, 2.88.
1
212.58C (dec); H NMR (CDCl3) d 8.04–7.99 (m, 2H),
7.75–7.64 (m, 6H), 7.17–7.01 (m, 5H), 4.81 (s, 1H), 4.25
(d, J¼7.3 Hz, 1H), 4.21–4.12 (m, 1H), 4.01–3.95 (m, 1H),
2.35 (s, 1H), 0.89 (t, J¼7.3 Hz, 3H); 31P NMR (CDCl3) d
221.2. Anal. calcd for C29H21F12O5P: C, 49.17; H, 2.99.
Found: C, 49.13; H, 2.78. 11-erythro-B: mp 156–1578C
4.1.4. (SpP,1R p)-1-(2-Oxo-1,2-diphenylethyl)-3,3,30,30-tet-
rakis(trifluoromethyl)-1,10-spirobi[3H,2,1l 5-benzoxa-
phosphole] (15-B). To benzylphosphorane 6 (1.00 g,
1.65 mmol) in THF (5 mL) was added n-BuLi (1.10 mL,
1.74 mol) at 08C. After stirring at rt for 5 m, benzoyl
chloride (0.200 mL, 1.72 mmol) was added and the
resulting mixture was stirred overnight. The solution was
quenched with water, extracted with Et2O and the combined
organic solvents were washed with water and brine. This
was followed by drying over anhydrous MgSO4 and
concentration in vacuo. Separation of the residue on TLC
(hexane–benzene¼1:1) followed by recrystallization
(hexane–CH2Cl2) gave 15-B (958 mg, 82%). Mp 160–
1618C; 1H NMR (CDCl3) d 8.17–8.12 (m, 2H), 7.76–7.19
(m, 14H), 6.97–6.95 (m, 2H), 5.91 (d, 2JPH¼18.6 Hz, 1H);
1
(dec); H NMR (CDCl3) d 8.26–8.21 (m, 2H), 7.72–7.61
(m, 6H), 7.21–7.00 (m, 5H), 5.34 (dd, J¼3.4 Hz,
2
2JPH¼7.4 Hz, 1H), 4.16 (dd, J¼3.4 Hz, JPH¼23.4 Hz,
1H), 3.96–3.89 (m, 2H), 0.89 (t, J¼7.3 Hz, 3H); 31P
NMR (CDCl3) d 225.0. Anal. calcd for C29H21F12O5P: C,
49.17; H, 2.99. Found: C, 49.10; H, 2.77.
4.1.2. (SpP,1S p,2R p)-1-(2-Hydroxy-1,2-diphenylethyl)-
3,3,30,30-tetrakis(trifluoromethyl)-1,10-spirobi[3H,2,1l 5-
benzoxaphosphole] (14-erythro-A) and (SpP,1R p,2S p)-1-
(2-hydroxy-1,2-diphenylethyl)-3,3,30,30-tetrakis(tri-
fluoromethyl)-1,10-spirobi[3H,2,1l 5-benzoxaphosphole]
(14-erythro-B). To P–H (equatorial) phosphorane 10
(196 mg, 0.380 mmol) in THF (2 mL) was added n-BuLi
(0.25 mL, 0.408 mol) at 08C. To this solution was added
trans- stilbene oxide (75.0 mg, 0.382 mmol) in THF (2 mL)
and the resulting mixture was stirred at rt for 5 h. The
solution was quenched with water, extracted with Et2O and
the combined organic solvents were washed with water and
brine. This was followed by drying over anhydrous MgSO4
and concentration in vacuo. Separation of the residue on
TLC (hexane–benzene¼2:1) followed by recrystallization
(hexane–CH2Cl2) gave 14-erythro-A (132.6 mg, 49%) and
14-erythro-B (78.2 mg, 29%). 14-erythro-A: mp 200.5–
4
19F NMR (CDCl3) d 273.9 (q, JFF¼10.0 Hz, 6F), 274.4
4
(q, JFF¼10.0 Hz, 6F); 31P NMR (CDCl3) d 225.2. Anal.
calcd for C32H19F12O3P: C, 54.10; H, 2.70. Found: C, 53.98;
H, 2.49.
4.1.5. (SpP,1S p)-1-(2-Oxo-1,2-diphenylethyl)-3,3,30,30-
tetrakis(trifluoromethyl)-1,10-spirobi[3H,2,1l 5-benz-
oxaphosphole] (15-A). A mixture of phosphorane 15-B
(300 mg, 0.422 mmol) and DBU (0.13 mL, 0.85 mmol) in
Et2O (3 mL) was stirred at rt for 52 h. After removal of
solvent, the residue was separated on TLC (hexane–
benzene¼1:1) followed by recrystallization (hexane–
1
CH2Cl2) to give 15-A (111 mg, 37%). Mp 189–1908C; H
1
201.58C (dec); H NMR (CDCl3) d 7.60–7.08 (m, 18H),
2
NMR (CDCl3)
d
7.70–7.12 (m, 18H), 5.91 (d,
5.36 (d, J¼10.3 Hz, 1H), 4.29 (dd, J¼10.3 Hz, JPH
¼
2JPH¼26.9 Hz, 1H); 19F NMR (CDCl3) d 273.5 (q,
19.5 Hz, 1H), 1.83 (s, 1H); 19F NMR (CDCl3) d 271.9 (q,
4JFF¼10.1 Hz, 6F), 273.3 (q, 4JFF¼10.1 Hz, 6F); 31P NMR
(CDCl3) d 221.9. Anal. calcd for C32H21F12O3P: C, 53.95;
H, 2.97. Found: C, 54.12; H, 2.87. 14-erythro-B: mp
4JFF¼9.8 Hz, 6F), 274.6 (q, JFF¼9.8 Hz, 6F); 31P NMR
4
(CDCl3) d 224.3. Anal. calcd for C32H19F12O3P: C, 54.10;
H, 2.70. Found: C, 54.08; H, 2.53.
1
203.5–204.58C (dec); H NMR (CDCl3) d 7.62–7.05 (m,
2
4.1.6. (SpP,1R p,2R p)-1-(2-Hydroxy-1,2-diphenylethyl)-
3,3,30,30-tetrakis(trifluoromethyl)-1,10-spirobi[3H,2,1l 5-
benzoxaphosphole] (14-threo-B). A mixture of phosphorane
18H), 5.31 (dd, J¼10.3 Hz, JPH¼4.9 Hz, 1H), 4.47 (dd,
2
J¼10.3 Hz, JPH¼16.1 Hz, 1H), 1.90 (s, 1H); 19F NMR